Nanobiotix (NBTX) Other Non-Current Liabilities (2019 - 2025)

Historic Other Non-Current Liabilities for Nanobiotix (NBTX) over the last 7 years, with Q2 2025 value amounting to $542208.6.

  • Nanobiotix's Other Non-Current Liabilities rose 3947.26% to $542208.6 in Q2 2025 from the same period last year, while for Jun 2025 it was $542208.6, marking a year-over-year increase of 3947.26%. This contributed to the annual value of $467570.1 for FY2024, which is 3382.29% up from last year.
  • Per Nanobiotix's latest filing, its Other Non-Current Liabilities stood at $542208.6 for Q2 2025, which was up 3947.26% from $461633.2 recorded in Q4 2024.
  • Over the past 5 years, Nanobiotix's Other Non-Current Liabilities peaked at $550352.1 during Q2 2021, and registered a low of $266764.2 during Q2 2022.
  • Its 5-year average for Other Non-Current Liabilities is $395876.2, with a median of $368142.5 in 2024.
  • As far as peak fluctuations go, Nanobiotix's Other Non-Current Liabilities crashed by 5152.85% in 2022, and later skyrocketed by 3947.26% in 2025.
  • Quarter analysis of 5 years shows Nanobiotix's Other Non-Current Liabilities stood at $550352.1 in 2021, then plummeted by 49.95% to $275466.8 in 2022, then rose by 26.16% to $347528.6 in 2023, then surged by 32.83% to $461633.2 in 2024, then grew by 17.45% to $542208.6 in 2025.
  • Its Other Non-Current Liabilities was $542208.6 in Q2 2025, compared to $461633.2 in Q4 2024 and $388756.4 in Q2 2024.